P D Abel

2.1k total citations
54 papers, 1.7k citations indexed

About

P D Abel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, P D Abel has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in P D Abel's work include Prostate Cancer Treatment and Research (14 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Urinary and Genital Oncology Studies (9 papers). P D Abel is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Urinary and Genital Oncology Studies (9 papers). P D Abel collaborates with scholars based in United Kingdom, United States and South Africa. P D Abel's co-authors include El–Nasir Lalani, G. Williams, Marc Laniado, Christopher S. Foster, Scott P. Fraser, J.A. Grimes, R. R. Hall, Gordon Stamp, Sanjeev Madaan and J. Brian McLoughlin and has published in prestigious journals such as Journal of Clinical Oncology, FEBS Letters and The Journal of Urology.

In The Last Decade

P D Abel

52 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P D Abel United Kingdom 22 598 503 416 261 190 54 1.7k
Manuel Sánchez‐Chapado Spain 24 560 0.9× 388 0.8× 646 1.6× 264 1.0× 154 0.8× 94 1.7k
Erik T. Goluboff United States 29 652 1.1× 538 1.1× 832 2.0× 198 0.8× 219 1.2× 69 2.5k
Hideki Fuse Japan 26 798 1.3× 412 0.8× 645 1.6× 540 2.1× 311 1.6× 217 2.7k
Dawn Dawson United States 21 921 1.5× 315 0.6× 258 0.6× 562 2.2× 196 1.0× 39 2.2k
Harriet O. Smith United States 29 860 1.4× 862 1.7× 296 0.7× 734 2.8× 885 4.7× 78 3.5k
Michael K. Fritsch United States 23 812 1.4× 292 0.6× 270 0.6× 142 0.5× 429 2.3× 57 1.5k
Jon Oxley United Kingdom 18 384 0.6× 226 0.4× 395 0.9× 171 0.7× 33 0.2× 54 1.1k
Hiroyuki Konaka Japan 22 475 0.8× 190 0.4× 447 1.1× 305 1.2× 92 0.5× 81 1.4k
Marc Laniado United Kingdom 17 420 0.7× 155 0.3× 438 1.1× 85 0.3× 81 0.4× 46 1.2k
Naohiro Fujimoto Japan 28 1.1k 1.9× 454 0.9× 1.2k 2.9× 471 1.8× 446 2.3× 181 2.8k

Countries citing papers authored by P D Abel

Since Specialization
Citations

This map shows the geographic impact of P D Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P D Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P D Abel more than expected).

Fields of papers citing papers by P D Abel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P D Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P D Abel. The network helps show where P D Abel may publish in the future.

Co-authorship network of co-authors of P D Abel

This figure shows the co-authorship network connecting the top 25 collaborators of P D Abel. A scholar is included among the top collaborators of P D Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P D Abel. P D Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Norman, Gill, Ruth E. Langley, Z. Hodges, et al.. (2008). Parenteral oestrogen in the treatment of prostate cancer: a systematic review. British Journal of Cancer. 98(4). 697–707. 23 indexed citations
3.
Sheikh, Soha El, Sanjeev Madaan, Ammar Alhasso, et al.. (2001). Cyclooxygenase‐2: a possible target in schistosoma‐associated bladder cancer. British Journal of Urology. 88(9). 921–927. 30 indexed citations
4.
Mitchell, Stephen, et al.. (2000). Phenotypic and genotypic characterization of commonly used human prostatic cell lines. British Journal of Urology. 85(7). 932–944. 113 indexed citations
5.
Stamp, Gordon, et al.. (1999). Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy.. Journal of Clinical Pathology. 52(1). 29–34. 19 indexed citations
6.
Lu, Qi Long, P D Abel, Ahmed M. Shoma, et al.. (1997). Expression of bcl‐2 and p53 oncoproteins in schistosomiasis‐associated transitional and squamous cell carcinoma of urinary bladder. British Journal of Urology. 79(1). 78–84. 44 indexed citations
7.
Stubbs, Andrew, El–Nasir Lalani, Gordon Stamp, et al.. (1996). Second messenger up‐regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC‐3 and DU‐145. FEBS Letters. 383(3). 237–240. 16 indexed citations
8.
Glover, Lesley, K. Gannon, Lorraine Sherr, & P D Abel. (1996). Differences between doctor and patient estimates of outcome in male sub‐fertility clinic attenders. British Journal of Clinical Psychology. 35(4). 531–542. 6 indexed citations
9.
Abel, P D, et al.. (1994). Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastics and malignant human prostatic epithelium. British Journal of Urology. 74(5). 609–616. 34 indexed citations
10.
McLoughlin, J. Brian, Christopher S. Foster, P. Price, G. Williams, & P D Abel. (1993). Evaluation of Ki‐67 Monoclonal Antibody as Prognostic Indicator for Prostatic Carcinoma. British Journal of Urology. 72(1). 92–97. 39 indexed citations
11.
Waxman, Jonathan, Claire Barton, Nicholas D. James, et al.. (1992). Bladder Cancer: Inter‐relationships between Chemotherapy and Radiotherapy. British Journal of Urology. 69(2). 151–155. 5 indexed citations
12.
Foster, Christopher S. & P D Abel. (1992). Clinical and molecular techniques for diagnosis and monitoring of prostatic cancer. Human Pathology. 23(4). 395–401. 11 indexed citations
13.
Foster, Christopher S., J. Brian McLoughlin, Imtiaz Bashir, & P D Abel. (1992). Markers of the metastatic phenotype in prostate cancer. Human Pathology. 23(4). 381–394. 32 indexed citations
14.
Abel, P D, Christopher S. Foster, Scott J. Tebbutt, & G. Williams. (1990). A study of oligosaccharide determinants expressed by prostatic glandular epithelium of the normal adult rat. Urological Research. 18(3). 233–237. 6 indexed citations
15.
McLoughlin, J. Brian, et al.. (1990). Visual Analogue Scales Distinguish between Low Urinary Flow Rates due to Impaired Detrusor Contractility and those due to Bladder Outflow Obstruction. British Journal of Urology. 66(1). 16–18. 3 indexed citations
16.
McLoughlin, J. Brian, Kiren Gill, P D Abel, & G. Williams. (1990). Symptoms versus Flow Rates versus Urodynamics in the Selection of Patients for Prostatectomy. British Journal of Urology. 66(3). 303–305. 39 indexed citations
17.
Abel, P D, Susan J. Thorpe, & G. Williams. (1989). Blood Group Antigen Expression in Frozen Sections of Presenting Bladder Cancer: 3‐year Prospective Follow‐up of Prognostic Value. British Journal of Urology. 63(2). 171–175. 6 indexed citations
18.
Abel, P D, et al.. (1989). Change in Glycoconjugate for the Binding Site of the Lectin Ulex europeus 1 following Malignant Transformation of Prostatic Epithelium. British Journal of Urology. 63(2). 183–185. 9 indexed citations
19.
Abel, P D, et al.. (1988). Differing Interpretations by Pathologists of the pT Category and Grade of Transitional Cell Cancer of the Bladder. British Journal of Urology. 62(4). 339–342. 80 indexed citations
20.
Cutner, A. & P D Abel. (1988). Undescended Testis: a Dual Lesson. British Journal of Urology. 62(3). 273–274. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Sánchez‐Chapado Breakdown of academic impact, for papers by Erik T. Goluboff Breakdown of academic impact, for papers by Hideki Fuse Breakdown of academic impact, for papers by Dawn Dawson Breakdown of academic impact, for papers by Harriet O. Smith Breakdown of academic impact, for papers by Michael K. Fritsch Breakdown of academic impact, for papers by Jon Oxley Breakdown of academic impact, for papers by Hiroyuki Konaka Breakdown of academic impact, for papers by Marc Laniado Breakdown of academic impact, for papers by Naohiro Fujimoto
Rankless by CCL
2026